DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Costa L, Caso F, Atteno M. et al.
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients.
Clin Rheumatol
33: 833-839
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.